Additional Information

Description

NAD+ Injection Olympia Lyophilized 500 mg is a compounded formulation intended for investigational use to support energy metabolism and address neurodegenerative diseases. NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme involved in various cellular processes, including energy production and DNA repair. This injectable product is typically used under medical supervision and is not FDA-approved, with limited clinical data supporting its safety and efficacy.

Although NAD+ has been studied for its potential benefits in energy metabolism and neurological conditions, the safety profile remains unclear due to a lack of large-scale clinical trials. Adverse events, including chills, vomiting, and fatigue, have been reported, and there is a potential risk of endotoxin contamination during the preparation of the product. Due to these concerns, it is important to administer the injection in a controlled medical environment.

The interactions of NAD+ with other medications remain poorly understood, as limited data exists regarding its effects when combined with various treatments. Patients must inform healthcare providers of all medications being used to avoid potential complications.